Additionally, several studies have reported that SOX9 could regulate the Wnt/β‐catenin pathway in human cancers (Cui et al., 2017; Guo et al., 2018; Santos et al., 2016), including HCC (Leung et al., 2016). This evidence concerns the gene SOX9 and hepatocellular carcinoma.